Acurx Pharmaceuticals, Inc. (ACXP) SEC filings
ACXP SEC filings moved a median of -2.02% by the close. ACXP SEC filings — 10-K, 10-Q, 8-K and the rest — each read against the price at its own news timestamp. Back to the ACXP overview →
80 measured ACXP SEC filing events.
Where these ACXP SEC filings landedvs 79 measured ACXP SEC filing reactions
| Middle 50% of ACXP SEC filing reactions | -5.52% to +1.45% |
|---|---|
| Median reaction (to close) | -2.02% |
| Measured reactions | 79 |
Point-in-time · zero look-ahead
Half of the 79 ACXP SEC filing events with a measured close landed between -5.52% and +1.45%; 37% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form EFFECT Acurx Pharmaceuticals, | SEC filing · Form EFFECT | +0.00% | +2.21% | |
| Form S-1 Acurx Pharmaceuticals, | SEC filing · Form S-1 | — | -1.40% | |
| Form ARS Acurx Pharmaceuticals, For: Dec 31 | SEC filing · Form ARS | +0.00% | +1.42% | |
| Form DEF 14A Acurx Pharmaceuticals, For: Oct 16 | SEC filing · Form DEF | +0.00% | +1.42% | |
| Form DEFA14A Acurx Pharmaceuticals, | SEC filing · Form DEFA14A | +0.00% | +1.42% | |
| Form 10-Q Acurx Pharmaceuticals, For: Jun 30 | SEC filing · Form 10-Q | -2.79% | -0.36% | |
| Form EFFECT Acurx Pharmaceuticals, | SEC filing · Form EFFECT | -3.21% | -5.96% | |
| Form 10-Q Acurx Pharmaceuticals, For: Mar 31 | SEC filing · Form 10-Q | -3.21% | -5.96% | |
| Form S-1 Acurx Pharmaceuticals, | SEC filing · Form S-1 | +0.96% | -4.31% | |
| Form D Acurx Pharmaceuticals, | SEC filing · Form D | +2.56% | +10.77% | |
| Form 8-K Acurx Pharmaceuticals, For: Apr 15 | SEC filing · Form 8-K | -10.93% | -1.58% | |
| New to The Street Resigns Acurx Pharmaceuticals, Inc. (NASDAQ:ACXP) to Continue Long-Form Interview Series, Outdoor Media Campaigns and Accredited Investor Events | Press release | +1.31% | +0.33% | |
| Form 10-K Acurx Pharmaceuticals, For: Dec 31 | SEC filing · Form 10-K | -1.65% | -8.71% | |
| Form S-8 Acurx Pharmaceuticals, | SEC filing · Form S-8 | -1.65% | -8.71% | |
| Form 8-K Acurx Pharmaceuticals, For: Mar 09 | SEC filing · Form 8-K | +3.21% | +39.64% | |
| Form EFFECT Acurx Pharmaceuticals, | SEC filing · Form EFFECT | -0.49% | -5.94% | |
| Form S-1 Acurx Pharmaceuticals, | SEC filing · Form S-1 | -1.25% | -5.39% | |
| Form EFFECT Acurx Pharmaceuticals, | SEC filing · Form EFFECT | +0.15% | -2.02% | |
| Form S-3/A Acurx Pharmaceuticals, | SEC filing · Form S-3 | -0.66% | -4.60% | |
| Form 10-Q Acurx Pharmaceuticals, For: Sep 30 | SEC filing · Form 10-Q | +3.99% | -5.32% | |
| Form S-1 Acurx Pharmaceuticals, | SEC filing · Form S-1 | +0.15% | +3.09% | |
| Form 8-K Acurx Pharmaceuticals, For: Sep 22 | SEC filing · Form 8-K | +0.00% | +2.25% | |
| Form 8-K Acurx Pharmaceuticals, For: Sep 16 | SEC filing · Form 8-K | -2.08% | +0.00% | |
| Acurx Pharmaceuticals, Inc. (NASDAQ:ACXP) Resigns with New to The Street for Long-Form Interviews, National TV Commercials, Earned Media, and Accredited Investor Events | Press release | +0.50% | +2.87% | |
| Form 10-Q Acurx Pharmaceuticals, For: Jun 30 | SEC filing · Form 10-Q | +0.00% | — | |
| Form DEF 14A Acurx Pharmaceuticals, For: Sep 16 | SEC filing · Form DEF | +1.34% | -9.11% | |
| Form DEFA14A Acurx Pharmaceuticals, | SEC filing · Form DEFA14A | -3.10% | -12.39% | |
| Form 8-K Acurx Pharmaceuticals, For: Jul 31 | SEC filing · Form 8-K | -1.50% | -4.12% | |
| Form PRE 14A Acurx Pharmaceuticals, For: Sep 16 | SEC filing · Form PRE | +0.05% | -5.65% | |
| Form EFFECT Acurx Pharmaceuticals, | SEC filing · Form EFFECT | -1.56% | -4.43% | |
| Form 8-K Acurx Pharmaceuticals, For: Jul 17 | SEC filing · Form 8-K | -1.88% | +4.65% | |
| Form S-1 Acurx Pharmaceuticals, | SEC filing · Form S-1 | +6.34% | -4.91% | |
| Form S-3 Acurx Pharmaceuticals, | SEC filing · Form S-3 | -1.52% | -3.85% | |
| Form D Acurx Pharmaceuticals, | SEC filing · Form D | +1.10% | +14.89% | |
| Form 8-K Acurx Pharmaceuticals, For: Jun 17 | SEC filing · Form 8-K | +0.65% | -19.12% | |
| Form EFFECT Acurx Pharmaceuticals, | SEC filing · Form EFFECT | +0.00% | +0.94% | |
| Form ARS Acurx Pharmaceuticals, For: Dec 31 | SEC filing · Form ARS | +0.00% | +0.94% | |
| Form DEF 14A Acurx Pharmaceuticals, For: Jul 17 | SEC filing · Form DEF | +0.00% | +0.94% | |
| Form DEFA14A Acurx Pharmaceuticals, | SEC filing · Form DEFA14A | +0.00% | +0.94% | |
| Form S-1 Acurx Pharmaceuticals, | SEC filing · Form S-1 | -0.25% | -0.70% | |
| Form D Acurx Pharmaceuticals, | SEC filing · Form D | +0.25% | +1.84% | |
| Form PRE 14A Acurx Pharmaceuticals, For: Jul 17 | SEC filing · Form PRE | -0.64% | +2.42% | |
| Form 8-K Acurx Pharmaceuticals, For: May 13 | SEC filing · Form 8-K | -0.20% | -2.59% | |
| Form 10-Q Acurx Pharmaceuticals, For: Mar 31 | SEC filing · Form 10-Q | -0.20% | -2.59% | |
| Form 8-K Acurx Pharmaceuticals, For: May 08 | SEC filing · Form 8-K | +0.79% | -5.26% | |
| Form EFFECT Acurx Pharmaceuticals, | SEC filing · Form EFFECT | -0.03% | -1.30% | |
| Form S-1 Acurx Pharmaceuticals, | SEC filing · Form S-1 | -0.03% | +2.56% | |
| Form 8-K Acurx Pharmaceuticals, For: Mar 25 | SEC filing · Form 8-K | -0.27% | -4.67% | |
| Form D Acurx Pharmaceuticals, | SEC filing · Form D | +0.31% | +0.81% | |
| Form EFFECT Acurx Pharmaceuticals, | SEC filing · Form EFFECT | -2.86% | +0.00% | |
| Form 8-K Acurx Pharmaceuticals, For: Mar 18 | SEC filing · Form 8-K | +0.50% | -15.46% | |
| Form 10-K Acurx Pharmaceuticals, For: Dec 31 | SEC filing · Form 10-K | +0.50% | -15.46% | |
| Form POS AM Acurx Pharmaceuticals, | SEC filing · Form POS | +0.50% | -15.46% | |
| Form S-8 Acurx Pharmaceuticals, | SEC filing · Form S-8 | +0.50% | -15.46% | |
| Form 8-K Acurx Pharmaceuticals, For: Mar 06 | SEC filing · Form 8-K | -2.06% | -4.23% | |
| Form 8-K Acurx Pharmaceuticals, For: Feb 24 | SEC filing · Form 8-K | -2.28% | -2.14% | |
| Form EFFECT Acurx Pharmaceuticals, | SEC filing · Form EFFECT | -1.68% | -0.03% | |
| Form S-1 Acurx Pharmaceuticals, | SEC filing · Form S-1 | -2.55% | -1.34% | |
| Form D Acurx Pharmaceuticals, | SEC filing · Form D | +0.00% | +0.00% | |
| Form 8-K Acurx Pharmaceuticals, For: Jan 06 | SEC filing · Form 8-K | -2.26% | -6.17% | |
| Form 8-K Acurx Pharmaceuticals, For: Nov 13 | SEC filing · Form 8-K | -3.70% | -3.70% | |
| Form 10-Q Acurx Pharmaceuticals, For: Sep 30 | SEC filing · Form 10-Q | -3.70% | -3.70% | |
| Form 8-K Acurx Pharmaceuticals, For: Aug 09 | SEC filing · Form 8-K | -4.74% | -10.90% | |
| Form 10-Q Acurx Pharmaceuticals, For: Jun 30 | SEC filing · Form 10-Q | -4.74% | -10.90% | |
| Form 8-K Acurx Pharmaceuticals, For: Jun 17 | SEC filing · Form 8-K | -2.66% | -7.03% | |
| Form 8-K Acurx Pharmaceuticals, For: May 15 | SEC filing · Form 8-K | +0.47% | +5.14% | |
| Form 10-Q Acurx Pharmaceuticals, For: Mar 31 | SEC filing · Form 10-Q | +0.47% | +5.14% | |
| Form ARS Acurx Pharmaceuticals, For: Dec 31 | SEC filing · Form ARS | +0.47% | +3.29% | |
| Form DEF 14A Acurx Pharmaceuticals, For: Jun 17 | SEC filing · Form DEF | +0.47% | +3.29% | |
| Form DEFA14A Acurx Pharmaceuticals, | SEC filing · Form DEFA14A | +0.47% | +3.29% | |
| Form RW Acurx Pharmaceuticals, | SEC filing · Form RW | -5.26% | +12.11% | |
| Form S-1/A Acurx Pharmaceuticals, | SEC filing · Form S-1 | +0.00% | -6.17% | |
| Form 8-K Acurx Pharmaceuticals, For: Mar 18 | SEC filing · Form 8-K | -2.09% | -11.71% | |
| Form S-1 Acurx Pharmaceuticals, | SEC filing · Form S-1 | -2.09% | -11.71% | |
| Form 10-K Acurx Pharmaceuticals, For: Dec 31 | SEC filing · Form 10-K | -1.12% | -3.00% | |
| Form S-8 Acurx Pharmaceuticals, | SEC filing · Form S-8 | -1.12% | -3.00% | |
| Form 8-K Acurx Pharmaceuticals, For: Nov 15 | SEC filing · Form 8-K | +2.05% | +6.16% | |
| Form 8-K Acurx Pharmaceuticals, For: Nov 14 | SEC filing · Form 8-K | -4.55% | +1.48% | |
| Form 10-Q Acurx Pharmaceuticals, For: Sep 30 | SEC filing · Form 10-Q | -2.56% | -2.02% | |
| Form 8-K Acurx Pharmaceuticals, For: Nov 02 | SEC filing · Form 8-K | -2.22% | +9.37% |
Keep exploring
More ACXP: earnings → · analyst actions → · ACXP overview →